Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

被引：0
|
作者：
Tada, S
Nakamuta, M
Tsuruta, S
Ohta, S
Fukutomi, M
Kuniyoshi, M
Enjoji, M
Nawata, H
机构：
[1] Fukuoka City Hosp, Fukuoka, Japan
[2] Kyushu Univ, Dept Med & Bioregulat Sci, Grad Sch Med Sci, Fukuoka 812, Japan
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
836
引用
收藏
页码：381A / 381A
页数：1
相关论文
共 50 条
  • [31] Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice
    Inoue, S
    Egashira, K
    Ni, WH
    Kitamoto, S
    Usui, M
    Otani, K
    Ishibashi, M
    Hiasa, K
    Nishida, K
    Takeshita, A
    CIRCULATION, 2002, 106 (21) : 2700 - 2706
  • [32] Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats
    Shin, Dong-Su
    Kim, Kung Wook
    Chung, Hae Young
    Yoon, Sik
    Moon, Jeon-Ok
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (05) : 608 - 618
  • [33] Anti-monocyte chemoattractant protein-1 gene therapy limits progression of established atherosclerosis to unstable plaques in apolipoprotein E-knockout mice
    Ni, WH
    Egashira, K
    Usui, M
    Inoue, S
    Kataoka, C
    Hiasa, KI
    Zhao, QW
    Ishibashi, M
    Kitamoto, S
    CIRCULATION, 2001, 104 (17) : 146 - 146
  • [34] Anti-monocyte chemoattractant protein-1 (MCP-1) gene therapy attenuates left ventricular remodeling and failure after myocardial infarction.
    Hayashidani, S
    Tsutsui, H
    Shiomi, T
    Suematsu, N
    Weng, J
    Takeshita, A
    CIRCULATION, 2001, 104 (17) : 214 - 214
  • [35] Effect of sinapic acid against dimethylnitrosamine-induced hepatic fibrosis in rats
    Dong-Su Shin
    Kung Wook Kim
    Hae Young Chung
    Sik Yoon
    Jeon-Ok Moon
    Archives of Pharmacal Research, 2013, 36 : 608 - 618
  • [36] Monocyte chemoattractant protein-1 gene and schizophrenia
    Mundo, E
    Altamura, AC
    Vismara, S
    Zanardini, R
    Bignotti, S
    Montresor, C
    Gennarelli, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 863 - 863
  • [37] Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis
    Egashira, K
    Koyanagi, M
    Kitamoto, S
    Ni, WH
    Kataoka, C
    Morishita, R
    Kaneda, Y
    Akiyama, C
    Nishida, KI
    Sueishi, K
    Takeshita, A
    FASEB JOURNAL, 2000, 14 (13): : 1974 - 1978
  • [38] Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting Stents attenuates in-stent stenosis in rabbits and monkeys
    Egashira, Kensuke
    Nakano, Kaku
    Ohtani, Kisho
    Funakoshi, Kouta
    Zhao, Gang
    Ihara, Yoshiko
    Koga, Jun-Ichiro
    Kimura, Satoshi
    Tominaga, Ryuji
    Sunagawa, Kenji
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (12) : 2563 - 2568
  • [39] LUNG MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE-EXPRESSION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    ZHANG, K
    GHARAEEKERMANI, M
    JONES, ML
    WARREN, JS
    PHAN, SH
    JOURNAL OF IMMUNOLOGY, 1994, 153 (10): : 4733 - 4741
  • [40] Anti-monocyte chemoattractant protein-1 monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries
    Furukawa, Y
    Matsumori, A
    Ohashi, N
    Shioi, T
    Ono, K
    Harada, A
    Matsushima, K
    Sasayama, S
    CIRCULATION RESEARCH, 1999, 84 (03) : 306 - 314
12345